International phase 3 clinical trial for new melanoma treatment recruits first patients
The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda
Read More
Tag: keytruda
IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial
The trial is evaluating an investigational cancer vaccine in combination with Keytruda
Read More
NICE gives green light for MSD’s Keytruda
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study
Read More
MSD’s Keytruda given go-ahead by SMC
Treatment concerns adults and adolescents with stage IIB or IIC melanoma skin cancer
Read More
NICE approves Merck’s Keytruda for adult patients with rare triple negative breast cancer
The injection is given in combination with chemotherapy and administered once every three weeks
Read More
Gilead and MSD collab on Trodelvy/Keytruda breast cancer trial
The companies will evaluate Trodelvy plus Keytruda for the first-line treatment of certain triple-negative breast cancer patients
Read More
EC approves Keytruda regimen for triple-negative breast cancer
Approval covers patients with locally recurrent or metastatic TNBC
Read More
FDA approves Keytruda plus Lenvima for advanced kidney cancer
Combination treatment reduced the risk of disease progression or death by 61% versus Sutent
Read More
Keytruda gains expanded US approval in skin cancer
Checkpoint inhibitor has been approved to treat locally advanced cutaneous squamous cell carcinoma
Read More
MSD’s Keytruda scores EU approval in certain oesophageal cancer patients
Checkpoint inhibitor approved in combination with chemotherapy in the first-line setting for these patients
Read More
Keytruda wins NICE backing in MSI-H/dMMR colorectal cancer
Immunotherapy recommended for use in patients with MSI/dMMR biomarkers
Read More
NHS England makes Keytruda available for advanced colorectal cancer during pandemic
Interim treatment agreement reached for eligible patients during COVID-19 pandemic
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
